SILVI, an open-source pipeline for T-cell epitope selection
High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet...
Gespeichert in:
| Veröffentlicht in: | PloS one Jg. 17; H. 9; S. e0273494 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
San Francisco
Public Library of Science
07.09.2022
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from
in silico
to
in vivo
), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and
https://doi.org/10.5281/zenodo.6865909
. |
|---|---|
| AbstractList | High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909. High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo ), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: https://github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909 . High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo ), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909 . High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909.High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909. |
| Audience | Academic |
| Author | Dorkeld, Franck Bonhomme, Vincent Holzmuller, Philippe Lemesre, Jean-Loup Loire, Etienne Sereno, Denis Pissarra, Joana |
| AuthorAffiliation | 3 UMR ASTRE, CIRAD, INRAE, University of Montpellier (I-MUSE), Montpellier, France 1 UMR INTERTRYP, IRD, CIRAD, University of Montpellier (I-MUSE), Montpellier, France 4 ISEM, CNRS, EPHE, IRD, University of Montpellier (I-MUSE), Montpellier, France National Cancer Institute at Frederick, UNITED STATES 2 UMR CBGP, INRAE, CIRAD, IRD, Montpellier SupAgro, University of Montpellier (I-MUSE), Montpellier, France |
| AuthorAffiliation_xml | – name: 3 UMR ASTRE, CIRAD, INRAE, University of Montpellier (I-MUSE), Montpellier, France – name: 2 UMR CBGP, INRAE, CIRAD, IRD, Montpellier SupAgro, University of Montpellier (I-MUSE), Montpellier, France – name: 1 UMR INTERTRYP, IRD, CIRAD, University of Montpellier (I-MUSE), Montpellier, France – name: 4 ISEM, CNRS, EPHE, IRD, University of Montpellier (I-MUSE), Montpellier, France – name: National Cancer Institute at Frederick, UNITED STATES |
| Author_xml | – sequence: 1 givenname: Joana orcidid: 0000-0002-0506-8042 surname: Pissarra fullname: Pissarra, Joana – sequence: 2 givenname: Franck surname: Dorkeld fullname: Dorkeld, Franck – sequence: 3 givenname: Etienne surname: Loire fullname: Loire, Etienne – sequence: 4 givenname: Vincent surname: Bonhomme fullname: Bonhomme, Vincent – sequence: 5 givenname: Denis orcidid: 0000-0002-0034-9291 surname: Sereno fullname: Sereno, Denis – sequence: 6 givenname: Jean-Loup surname: Lemesre fullname: Lemesre, Jean-Loup – sequence: 7 givenname: Philippe surname: Holzmuller fullname: Holzmuller, Philippe |
| BackLink | https://hal.inrae.fr/hal-03808360$$DView record in HAL |
| BookMark | eNqNk12L1DAUhousuB_6DwQLgrhgx3w2DYIwLOoODCy4696GNDmdydBpuk276L83dapsl72QXCScPOdNzpuc0-So8Q0kyWuMFpgK_HHnh67R9aKN4QUigjLJniUnWFKS5QTRowfr4-Q0hB1CnBZ5_iI5pjkSiHBykny6Xq1vVx9S3aS-hSYLUdVA2roWatdAWvkuvckM1HUKresjkwaowfTONy-T55WuA7ya5rPkx9cvNxeX2frq2-piuc5MzkmfEYtLYZjgOUiEpeSFkQaVCDAvpADghGIMlpfWQlmIilcgJLLIamMpLSk9S94cdNvaBzXVHRQRGBMmmJCRWB0I6_VOtZ3b6-6X8tqpPwHfbZTuemdqUESChYqVlEvMWIG1tlTmuqSVLXKCIWp9nk4byj1YA03f6XomOt9p3FZt_L2SjGMkRBQ4PwhsH6VdLtdqjCFaoCI-wT2O7PvpsM7fDRB6tXdhdFs34IdDjRTlORldePsIfdqJidroWKxrKh_vaEZRtRQ4Z7SIWKQWT1BxWNg7Ez9U5WJ8lnA-S4hMDz_7jR5CUKvr7__PXt3O2XcP2C3out8GXw_j9wpzkB1A0_kQOqj-OYuRGvvhrxtq7Ac19QP9DQKp-mc |
| Cites_doi | 10.1016/j.jim.2015.03.022 10.1016/j.humimm.2015.11.012 10.1093/nar/gkh435 10.4161/hv.36134 10.1002/eji.201343726 10.1371/journal.pone.0115745 10.1111/j.0105-2896.2005.00307.x 10.4049/jimmunol.178.11.7181 10.4049/jimmunol.160.7.3363 10.1007/s002510050595 10.1038/npjvaccines.2016.9 10.1007/s00251-015-0873-y 10.32614/CRAN.package.tidyverse 10.1111/obr.12605 10.1038/360434a0 10.1016/j.vaccine.2012.01.033 10.4049/jimmunol.165.2.1123 10.32614/CRAN.package.Peptides 10.1111/j.1365-2249.2004.02371.x 10.1186/1471-2105-11-568 10.1093/bioinformatics/btv123 10.1016/j.meegid.2016.10.002 10.1186/1471-2105-13-309 10.2174/138161210793292447 10.1093/bib/bbr060 10.4049/jimmunol.1103008 10.1002/eji.200636783 10.7554/eLife.32402 10.1016/j.vaccine.2008.09.085 10.1111/iji.12214 10.1016/j.coi.2014.01.009 10.1111/j.0105-2896.2005.00301.x 10.1046/j.1365-3024.2000.00331.x 10.4049/jimmunol.1700893 10.1016/j.immuni.2005.05.009 10.1155/2013/521231 10.1016/0022-2836(82)90515-0 10.3389/fimmu.2014.00260 10.1371/journal.pone.0058309 10.1146/annurev-med-051214-024241 10.1186/1472-6750-6-35 10.1038/nrd2224 10.1016/j.micpath.2012.07.002 10.1093/nar/gkw1099 10.1099/vir.0.82826-0 10.1371/journal.pcbi.1003266 10.1098/rsob.120139 10.1093/nar/gkw1105 10.1016/j.vaccine.2015.03.072 10.1016/j.tibtech.2007.12.006 10.1371/journal.ppat.1002759 10.1038/nbt1215 10.1146/annurev.immunol.17.1.51 10.1186/1471-2105-14-211 10.1073/pnas.95.1.270 10.1016/j.immuni.2010.09.017 10.1002/9781118345313 10.1093/nar/gku938 10.1371/journal.pcbi.1000048 10.4049/jimmunol.172.9.5561 10.1016/j.addr.2009.07.001 10.1093/inthealth/ihv002 10.1186/1745-7580-6-S2-S3 10.1002/eji.200535035 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2022 Public Library of Science 2022 Pissarra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. licence_http://creativecommons.org/publicdomain/zero 2022 Pissarra et al 2022 Pissarra et al |
| Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Pissarra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: licence_http://creativecommons.org/publicdomain/zero – notice: 2022 Pissarra et al 2022 Pissarra et al |
| DBID | AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 1XC VOOES 5PM DOA |
| DOI | 10.1371/journal.pone.0273494 |
| DatabaseName | CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journal Collection |
| DatabaseTitle | CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Computer Science |
| DocumentTitleAlternate | SILVI, an open-source pipeline for T-cell epitope selection |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2711247479 oai_doaj_org_article_29edef4b35914481aad396ab3fd8621e PMC9451077 oai:HAL:hal-03808360v1 A716438747 10_1371_journal_pone_0273494 |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GrantInformation_xml | – fundername: ; – fundername: ; grantid: 642609 – fundername: ; grantid: ANR-11-LABX-0024-PARAFRAP |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAIFH BAWUL BBNVY BBTPI BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ALIPV BBORY 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO ESTFP FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 1XC VOOES 5PM AAPBV ABPTK BBAFP N95 |
| ID | FETCH-LOGICAL-c652t-2d1b7c4756e9019958c9c0b0e15897ee52311ed5bddeb87f5fe790d0dacd33b33 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000933379100025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Mon Dec 05 23:08:03 EST 2022 Fri Oct 03 12:28:27 EDT 2025 Tue Nov 04 01:59:47 EST 2025 Thu Nov 06 12:50:01 EST 2025 Sun Nov 09 11:57:40 EST 2025 Tue Oct 07 07:51:16 EDT 2025 Sat Nov 29 13:04:32 EST 2025 Sat Nov 29 10:11:32 EST 2025 Wed Nov 26 10:02:16 EST 2025 Wed Nov 26 10:24:27 EST 2025 Thu May 22 21:23:34 EDT 2025 Sat Nov 29 04:08:28 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c652t-2d1b7c4756e9019958c9c0b0e15897ee52311ed5bddeb87f5fe790d0dacd33b33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors declare no competing interests exist. |
| ORCID | 0000-0002-0034-9291 0000-0002-0506-8042 0000-0001-8447-9730 0000-0002-2742-6349 0000-0002-8919-9081 |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pone.0273494 |
| PMID | 36070252 |
| PQID | 2711247479 |
| PQPubID | 1436336 |
| PageCount | e0273494 |
| ParticipantIDs | plos_journals_2711247479 doaj_primary_oai_doaj_org_article_29edef4b35914481aad396ab3fd8621e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9451077 hal_primary_oai_HAL_hal_03808360v1 proquest_miscellaneous_2711306623 proquest_journals_2711247479 gale_infotracmisc_A716438747 gale_infotracacademiconefile_A716438747 gale_incontextgauss_ISR_A716438747 gale_incontextgauss_IOV_A716438747 gale_healthsolutions_A716438747 crossref_primary_10_1371_journal_pone_0273494 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-09-07 |
| PublicationDateYYYYMMDD | 2022-09-07 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | San Francisco |
| PublicationPlace_xml | – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | T Hagan (pone.0273494.ref016) 2015; 33 R Vita (pone.0273494.ref014) 2015; 43 L Zhang (pone.0273494.ref031) 2012; 13 JJA Calis (pone.0273494.ref012) 2013; 9 V Jurtz (pone.0273494.ref068) 2017; 199 H-G Rammensee (pone.0273494.ref070) 1999; 50 A Sette (pone.0273494.ref035) 2010; 33 CA Weber (pone.0273494.ref044) 2009; 61 V Dutoit (pone.0273494.ref056) 2005; 35 V. Desai D (pone.0273494.ref027) 2014 M Castelli (pone.0273494.ref034) 2013; 2013 KP Burke (pone.0273494.ref049) 2012; 188 R Axelsson-Robertson (pone.0273494.ref053) 2013; 8 M Pinder (pone.0273494.ref058) 2004; 135 A Bateman (pone.0273494.ref064) 2017; 45 A Patronov (pone.0273494.ref005) 2013; 3 M Wang (pone.0273494.ref072) 2014 T. Aebischer (pone.0273494.ref036) 2014; 5 D Serruto (pone.0273494.ref002) 2012; 30 C Lundegaard (pone.0273494.ref024) 2010; 6 M Moutaftsi (pone.0273494.ref069) 2006; 24 J Kyte (pone.0273494.ref073) 1982; 157 AW Purcell (pone.0273494.ref008) 2007; 6 JW Yewdell (pone.0273494.ref037) 1999; 17 S Southwood (pone.0273494.ref060) 1998; 160 KL Rock (pone.0273494.ref041) 2005; 207 C Neumann-Haefelin (pone.0273494.ref048) 2007; 88 AVS Hill (pone.0273494.ref052) 1992; 360 SH Kaufmann (pone.0273494.ref015) 2014; 28 P Wang (pone.0273494.ref030) 2010; 11 pone.0273494.ref007 T Trolle (pone.0273494.ref062) 2015; 31 S Vivona (pone.0273494.ref023) 2008; 26 S Vivona (pone.0273494.ref018) 2006; 6 P Holzmuller (pone.0273494.ref021) 2016; 45 SJ Goodswen (pone.0273494.ref004) 2014; 9 Y He (pone.0273494.ref019) 2010; 297505 P Wang (pone.0273494.ref033) 2008; 4 DL Doolan (pone.0273494.ref059) 2000; 165 A Lalvani (pone.0273494.ref054) 1998; 95 FA Castelli (pone.0273494.ref057) 2007; 37 SP Singh (pone.0273494.ref029) 2016; 77 M Andreatta (pone.0273494.ref071) 2015; 67 NL Dudek (pone.0273494.ref010) 2010; 16 AS De Groot (pone.0273494.ref042) 2015; 10 AJ Sant (pone.0273494.ref039) 2005; 207 S Paul (pone.0273494.ref013) 2014; 191 V Jaiswal (pone.0273494.ref017) 2013; 14 L Liljeroos (pone.0273494.ref025) 2015; 156241 CA Lazarski (pone.0273494.ref038) 2005; 23 L Backert (pone.0273494.ref006) 2015 DM Resende (pone.0273494.ref040) 2012; 13 H Nagai (pone.0273494.ref061) 2014 C Aurrecoechea (pone.0273494.ref063) 2017; 45 R Wang (pone.0273494.ref050) 2004; 172 JM González (pone.0273494.ref051) 2000; 22 P Oyarzun (pone.0273494.ref011) 2015; 42 J Min (pone.0273494.ref022) 2018; 19 S Paul (pone.0273494.ref074) 2015; 422 Y Wang (pone.0273494.ref055) 2012; 53 A Ferrante (pone.0273494.ref032) 2007; 178 S Noazin (pone.0273494.ref043) 2008; 26 pone.0273494.ref065 SK Dhanda (pone.0273494.ref001) 2017; 18 J Settleman (pone.0273494.ref009) 2018; 7 pone.0273494.ref066 pone.0273494.ref067 PJ Hotez (pone.0273494.ref003) 2016; 67 pone.0273494.ref028 F Legoux (pone.0273494.ref046) 2013; 43 AI Heinson (pone.0273494.ref020) 2015; 7 D Franceschini (pone.0273494.ref047) 2012; 8 S McGinnis (pone.0273494.ref045) 2004; 32 N Tomar (pone.0273494.ref026) 2014 |
| References_xml | – volume: 422 start-page: 28 year: 2015 ident: pone.0273494.ref074 article-title: Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes publication-title: J Immunol Methods doi: 10.1016/j.jim.2015.03.022 – volume: 77 start-page: 295 year: 2016 ident: pone.0273494.ref029 article-title: Major histocompatibility complex linked databases and prediction tools for designing vaccines publication-title: Hum Immunol doi: 10.1016/j.humimm.2015.11.012 – volume: 32 start-page: W20 year: 2004 ident: pone.0273494.ref045 article-title: BLAST: At the core of a powerful and diverse set of sequence analysis tools publication-title: Nucleic Acids Res doi: 10.1093/nar/gkh435 – volume-title: Immunoinformatics. Methods in Molecular Biology (Methods and Protocols) year: 2014 ident: pone.0273494.ref026 – volume: 10 start-page: 3570 year: 2015 ident: pone.0273494.ref042 article-title: Immune camouflage: Relevance to vaccines and human immunology publication-title: Hum Vaccin Immunother doi: 10.4161/hv.36134 – volume: 43 start-page: 3244 year: 2013 ident: pone.0273494.ref046 article-title: Characterization of the human CD4+ T-cell repertoire specific for major histocompatibility class I-restricted antigens publication-title: Eur J Immunol doi: 10.1002/eji.201343726 – volume: 9 start-page: e115745 year: 2014 ident: pone.0273494.ref004 article-title: Enhancing in silico protein-based vaccine discovery for eukaryotic pathogens using predicted peptide-MHC binding and peptide conservation scores publication-title: PLoS One doi: 10.1371/journal.pone.0115745 – volume: 207 start-page: 261 year: 2005 ident: pone.0273494.ref039 article-title: The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes publication-title: Immunol Rev doi: 10.1111/j.0105-2896.2005.00307.x – volume: 178 start-page: 7181 year: 2007 ident: pone.0273494.ref032 article-title: Cooperativity of hydrophobic anchor interactions: evidence for epitope selection by MHC class II as a folding process publication-title: J Immunol doi: 10.4049/jimmunol.178.11.7181 – volume: 160 start-page: 3363 year: 1998 ident: pone.0273494.ref060 article-title: Several common HLA-DR types share largely overlapping peptide binding repertoires publication-title: J Immunol doi: 10.4049/jimmunol.160.7.3363 – volume: 50 start-page: 213 year: 1999 ident: pone.0273494.ref070 article-title: SYFPEITHI: database for MHC ligands and peptide motifs publication-title: Immunogenetics doi: 10.1007/s002510050595 – ident: pone.0273494.ref007 doi: 10.1038/npjvaccines.2016.9 – volume: 67 start-page: 641 year: 2015 ident: pone.0273494.ref071 article-title: Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification publication-title: Immunogenetics doi: 10.1007/s00251-015-0873-y – ident: pone.0273494.ref065 doi: 10.32614/CRAN.package.tidyverse – volume: 19 start-page: 49 year: 2018 ident: pone.0273494.ref022 article-title: Double burden of diseases worldwide: coexistence of undernutrition and overnutrition-related non-communicable chronic diseases publication-title: Obes Rev doi: 10.1111/obr.12605 – volume: 360 start-page: 434 year: 1992 ident: pone.0273494.ref052 article-title: Molecular analysis of the association of HLA-B53 and resistance to severe malaria publication-title: Nature doi: 10.1038/360434a0 – volume: 30 start-page: B87 year: 2012 ident: pone.0273494.ref002 article-title: The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens publication-title: Vaccine doi: 10.1016/j.vaccine.2012.01.033 – volume: 165 start-page: 1123 year: 2000 ident: pone.0273494.ref059 article-title: HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles publication-title: J Immunol doi: 10.4049/jimmunol.165.2.1123 – ident: pone.0273494.ref067 doi: 10.32614/CRAN.package.Peptides – volume: 135 start-page: 286 year: 2004 ident: pone.0273494.ref058 article-title: Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2004.02371.x – volume: 11 start-page: 568 year: 2010 ident: pone.0273494.ref030 article-title: Peptide binding predictions for HLA DR, DP and DQ molecules publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-11-568 – volume: 31 start-page: 2174 year: 2015 ident: pone.0273494.ref062 article-title: Automated benchmarking of peptide-MHC class I binding predictions publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv123 – volume: 45 start-page: 426 year: 2016 ident: pone.0273494.ref021 article-title: The transcriptomic analytical level determines the human monocyte-derived macrophage response toward either the infectious agent or the host publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2016.10.002 – volume: 13 start-page: 309 year: 2012 ident: pone.0273494.ref040 article-title: An assessment on epitope prediction methods for protozoa genomes publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-13-309 – volume: 16 start-page: 3149 year: 2010 ident: pone.0273494.ref010 article-title: Epitope discovery and their use in peptide based vaccines publication-title: Curr Pharm Des doi: 10.2174/138161210793292447 – volume: 13 start-page: 350 year: 2012 ident: pone.0273494.ref031 article-title: Toward more accurate pan-specific MHC-peptide binding prediction: A review of current methods and tools publication-title: Brief Bioinform doi: 10.1093/bib/bbr060 – volume: 188 start-page: 5177 year: 2012 ident: pone.0273494.ref049 article-title: Immunogenicity and Cross-Reactivity of a Representative Ancestral Sequence in Hepatitis C Virus Infection publication-title: J Immunol doi: 10.4049/jimmunol.1103008 – volume: 37 start-page: 1513 year: 2007 ident: pone.0273494.ref057 article-title: Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins publication-title: Eur J Immunol doi: 10.1002/eji.200636783 – volume: 7 start-page: e32402 year: 2018 ident: pone.0273494.ref009 article-title: Challenges in validating candidate therapeutic targets in cancer publication-title: Elife doi: 10.7554/eLife.32402 – volume-title: Immunoinformatics Methods in Molecular Biology (Methods and Protocols) year: 2014 ident: pone.0273494.ref027 – volume: 26 start-page: 6759 year: 2008 ident: pone.0273494.ref043 article-title: First generation leishmaniasis vaccines: A review of field efficacy trials publication-title: Vaccine doi: 10.1016/j.vaccine.2008.09.085 – start-page: 309 volume-title: Immunoinformatics Methods in Molecular Biology (Methods and Protocols) year: 2014 ident: pone.0273494.ref072 – start-page: 2014 year: 2014 ident: pone.0273494.ref061 article-title: Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients publication-title: J Immunol Res – volume: 42 start-page: 313 year: 2015 ident: pone.0273494.ref011 article-title: Computer-aided design of T-cell epitope-based vaccines: addressing population coverage publication-title: Int J Immunogenet doi: 10.1111/iji.12214 – volume: 28 start-page: 18 year: 2014 ident: pone.0273494.ref015 article-title: Challenges and responses in human vaccine development publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2014.01.009 – volume: 207 start-page: 166 year: 2005 ident: pone.0273494.ref041 article-title: Cross-presentation: underlying mechanisms and role in immune surveillance publication-title: Immunol Rev doi: 10.1111/j.0105-2896.2005.00301.x – volume: 22 start-page: 501 year: 2000 ident: pone.0273494.ref051 article-title: HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: Identification of new Plasmodium falciparum epitopes by IFN-γ ELISPOT publication-title: Parasite Immunol doi: 10.1046/j.1365-3024.2000.00331.x – volume: 199 start-page: 3360 year: 2017 ident: pone.0273494.ref068 article-title: NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data publication-title: J Immunol doi: 10.4049/jimmunol.1700893 – start-page: 1 year: 2015 ident: pone.0273494.ref006 article-title: Immunoinformatics and epitope prediction in the age of next-generation sequencing and personalized medicine publication-title: Genome Med – volume: 23 start-page: 29 year: 2005 ident: pone.0273494.ref038 article-title: The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance publication-title: Immunity doi: 10.1016/j.immuni.2005.05.009 – volume: 2013 year: 2013 ident: pone.0273494.ref034 article-title: Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides publication-title: Clin Dev Immunol doi: 10.1155/2013/521231 – ident: pone.0273494.ref066 – volume: 297505 year: 2010 ident: pone.0273494.ref019 article-title: Vaxign: The first web-based vaccine design program for reverse vaccinology and applications for vaccine development publication-title: J Biomed Biotechnol – volume: 157 start-page: 105 year: 1982 ident: pone.0273494.ref073 article-title: A simple method for displaying the hydropathic character of a protein publication-title: J Mol Biol doi: 10.1016/0022-2836(82)90515-0 – volume: 5 start-page: 260 year: 2014 ident: pone.0273494.ref036 article-title: Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis publication-title: Front Immunol doi: 10.3389/fimmu.2014.00260 – volume: 8 year: 2013 ident: pone.0273494.ref053 article-title: A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis publication-title: PLoS One doi: 10.1371/journal.pone.0058309 – volume: 67 start-page: 405 year: 2016 ident: pone.0273494.ref003 article-title: New Vaccines for the World’s Poorest People publication-title: Annu Rev Med doi: 10.1146/annurev-med-051214-024241 – volume: 6 start-page: 35 year: 2006 ident: pone.0273494.ref018 article-title: NERVE: New Enhanced Reverse Vaccinology Environment publication-title: BMC Biotechnol doi: 10.1186/1472-6750-6-35 – volume: 6 start-page: 404 year: 2007 ident: pone.0273494.ref008 article-title: More than one reason to rethink the use of peptides in vaccine design publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2224 – volume: 53 start-page: 162 year: 2012 ident: pone.0273494.ref055 article-title: Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele publication-title: Microb Pathog doi: 10.1016/j.micpath.2012.07.002 – volume: 18 start-page: 467 year: 2017 ident: pone.0273494.ref001 article-title: Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics publication-title: Brief Bioinform – volume: 45 start-page: D158 year: 2017 ident: pone.0273494.ref064 article-title: UniProt: the universal protein knowledgebase publication-title: Nucleic Acids Res doi: 10.1093/nar/gkw1099 – volume: 88 start-page: 1986 year: 2007 ident: pone.0273494.ref048 article-title: Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site publication-title: J Gen Virol doi: 10.1099/vir.0.82826-0 – volume: 9 start-page: e1003266 year: 2013 ident: pone.0273494.ref012 article-title: Properties of MHC Class I Presented Peptides That Enhance Immunogenicity publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1003266 – volume: 3 start-page: 120139 year: 2013 ident: pone.0273494.ref005 article-title: T-cell epitope vaccine design by immunoinformatics publication-title: Open Biol doi: 10.1098/rsob.120139 – volume: 45 start-page: D581 year: 2017 ident: pone.0273494.ref063 article-title: EuPathDB: the eukaryotic pathogen genomics database resource publication-title: Nucleic Acids Res doi: 10.1093/nar/gkw1105 – volume: 33 start-page: 5294 year: 2015 ident: pone.0273494.ref016 article-title: Systems vaccinology: Enabling rational vaccine design with systems biological approaches publication-title: Vaccine doi: 10.1016/j.vaccine.2015.03.072 – volume: 26 start-page: 190 year: 2008 ident: pone.0273494.ref023 article-title: Computer-aided biotechnology: from immuno-informatics to reverse vaccinology publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2007.12.006 – volume: 8 start-page: e1002759 year: 2012 ident: pone.0273494.ref047 article-title: Polyfunctional type-1, -2, and -17 CD8+ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002759 – volume: 24 start-page: 817 year: 2006 ident: pone.0273494.ref069 article-title: A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus publication-title: Nat Biotechnol doi: 10.1038/nbt1215 – volume: 17 start-page: 51 year: 1999 ident: pone.0273494.ref037 article-title: Immunodominance in major histocompatibility complex class I–restricted T lymphocyte responses publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.17.1.51 – volume: 156241 year: 2015 ident: pone.0273494.ref025 article-title: Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens publication-title: J Immunol Res – volume: 14 start-page: 211 year: 2013 ident: pone.0273494.ref017 article-title: Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-211 – volume: 95 start-page: 270 year: 1998 ident: pone.0273494.ref054 article-title: Human cytolytic and interferon γ-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.1.270 – volume: 33 start-page: 530 year: 2010 ident: pone.0273494.ref035 article-title: Reverse Vaccinology: Developing Vaccines in the Era of Genomics publication-title: Immunity doi: 10.1016/j.immuni.2010.09.017 – ident: pone.0273494.ref028 doi: 10.1002/9781118345313 – volume: 191 start-page: 6 year: 2014 ident: pone.0273494.ref013 publication-title: HLA class I alleles are associated with peptide binding repertoires of different size, affinity and immunogenicity – volume: 43 start-page: D405 year: 2015 ident: pone.0273494.ref014 article-title: The immune epitope database (IEDB) 3.0 publication-title: Nucleic Acids Res doi: 10.1093/nar/gku938 – volume: 4 start-page: e1000048 year: 2008 ident: pone.0273494.ref033 article-title: A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1000048 – volume: 172 start-page: 5561 year: 2004 ident: pone.0273494.ref050 article-title: Induction in Humans of CD8 + and CD4 + T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein publication-title: J Immunol doi: 10.4049/jimmunol.172.9.5561 – volume: 61 start-page: 965 year: 2009 ident: pone.0273494.ref044 article-title: T cell epitope: Friend or Foe? Immunogenicity of biologics in context publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2009.07.001 – volume: 7 start-page: 85 year: 2015 ident: pone.0273494.ref020 article-title: The promise of reverse vaccinology publication-title: Int Health doi: 10.1093/inthealth/ihv002 – volume: 6 start-page: S3 year: 2010 ident: pone.0273494.ref024 article-title: State of the art and challenges in sequence based T-cell epitope prediction publication-title: Immunome Res doi: 10.1186/1745-7580-6-S2-S3 – volume: 35 start-page: 3493 year: 2005 ident: pone.0273494.ref056 article-title: Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection publication-title: Eur J Immunol doi: 10.1002/eji.200535035 |
| SSID | ssj0053866 |
| Score | 2.3989537 |
| Snippet | High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based... |
| SourceID | plos doaj pubmedcentral hal proquest gale crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e0273494 |
| SubjectTerms | Algorithms Analysis Antigenic determinants Antigens Binding Biochemistry, Molecular Biology Bioinformatics Biology and Life Sciences Chemical properties Computer Science Epitopes Evaluation Fluid filters Genomes Genomics Health aspects Hepatitis C High-throughput screening Histocompatibility antigen HLA Human papillomavirus Hydrophobicity Immunogenicity Immunotherapy Leukocytes Life Sciences Localization Lymphocytes T Medicine and Health Sciences Microorganisms Modeling and Simulation Pathogens Peptides Predictions Proteins Proteomes Public software Research and Analysis Methods T cells Tuberculosis Vaccines Workflow |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journal Collection dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgxYELojzUlAIBIQESaePYjm1xWhBVV1oVREvVm2UnNrsSykbNbn8_M0l2VUtIcOAaT17feMYzycxnQt6UgknLrciEhUyHh0Azp6nLeFFLz7UM1Pc8s3N5dqaurvS3W1t9YU3YQA88AHdcaF_7wB0TGmJ_Ra2tmS6tY6GGYJx69L4Q9WyTqcEHgxWX5dgoxyQ9HvVy1K4af9QzumgeLUQ9X__OK99dYFHkpP216qLAMy6bvLUOnTwkD8YAMp0OD75H7vjmEdkbTbRL34080u8fk4_ns_nl7ENqmxT3yMqG7_Rpu2yxB92nEK6mFxl-uU99C4bd-rTrd8UBVT0hP06-XHw-zca9ErKqFMU6K2rqZMWlKD2s8FoLVekqd7mnQmnpPeSblPpaOHBnTskggpc6r_PaVjVjjrGnZNIAOvskVVaDykIlXKW4UMExyzHvg9BCw0JXJiTbAmfagRLD9P_FJKQSAwgGgTYj0An5hOjuZJHQuj8Aajajms3f1JyQl6gbM3SH7szSTDHfYwqSooS87iWQ1KLBqpmfdtN1Zvb18h-Ezr9HQm9HobACRVd27FSAd0KyrEjyMJIE06ziuy0QjFsvfjqdGzyWM4W84PkNTcg-TrQtdJ0pJMTAHE7XcPnt5Pvz8KvdMN4Zy-Uav9oMMgy5_VlCZDRpo4eJR5rloqcX1xz8tJQH_0Ntz8j9AvtF8A-cPCST9fXGPyf3qpv1srt-0dvsb-yDRNY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest advanced technologies & aerospace journals dbid: P5Z link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdY4YEXYHxoYQMCQgIkssWxHcfiARXEtErVmNiYJl4sO3HWSijJmnZ_P3eJWxYJISRe41Nd35fv7PPvCHmdCiYNNyISBjIdXpY0soraiCeFdFzJkroOZ3Yqj4-ziwt14g_cWl9WufaJnaMu6hzPyA8SCZEBh-BXfWyuIuwahbervoXGFrmNKAlomCfix9oTgy2nqX8uxyQ98NLZb-rK7Xe4LooPtqMOtX_jm7dmWBo5an7W7SD8HBZP3tiNDu__7zoekHs-Dg3HveJsk1uueki2vaW34VsPR_3uEflwOpmeT96Hpgqx1VbUH_eHzbzBp-wuhKg3PIvwAiB0DfiHxoVt11wHJP6YfD_8cvb5KPItF6I8FckySgpqZc6lSB0ECkqJLFd5bGNHRaakc5C2UuoKYcEr2kyWonRSxUVcmLxgzDL2hIwqYO8OCTOjQPJlLmyecZGVlhmO6SNEKAr2yzQg0ZrzuumRNXR3vSYhI-mZoFFS2ksqIJ9QPBtaxMXuPtSLS-3NTCfKFa7klgkFmWJGjSmYSo1lZQGpG3UBeYHC1f0j04116zGmjSwDsQTkVUeB2BgVFt9cmlXb6snX838gOv02IHrjicoaNCU3_sEDrAkxtwaUewNKsPB8ONsMmXFj4UfjqcZvMcsQXjy-pgHZQU1ds67VvxUNfn6tin8efrkZxpmx6q5y9aqnYdgigAVEDrR-8GeGI9V81qGUKw7uXsqnf598l9xN8EEJXtHJPTJaLlbuGbmTXy_n7eJ5Z86_AOkOUok priority: 102 providerName: ProQuest |
| Title | SILVI, an open-source pipeline for T-cell epitope selection |
| URI | https://www.proquest.com/docview/2711247479 https://www.proquest.com/docview/2711306623 https://hal.inrae.fr/hal-03808360 https://pubmed.ncbi.nlm.nih.gov/PMC9451077 https://doaj.org/article/29edef4b35914481aad396ab3fd8621e http://dx.doi.org/10.1371/journal.pone.0273494 |
| Volume | 17 |
| WOSCitedRecordID | wos000933379100025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1db9Mw0KIdD7wA40MLjBIQEiCREsdxbIundlq1al2J2lF1vERO4tBKKI2Wdr-fuzQtC2ISvNyDfU7s8519Z9-dCXkXcCa0r7nDNVg6fpZRJ1Y0dnwvFcZXIqOmyjM7EuOxnM9V-NtQ_OMGnwn6uaZpt1jlpltlY1F-ixx4LAjQhWsQjnYrL8huENThcXe1bGw_VZb-_VrcWqArZLv4uSob6mbTWfLW7jN49L_9fkwe1nqm3dsyxiG5Z_In5LCW5NL-UKeb_viUfJkOR7PhJ1vnNj6l5WyP8-1iWWCourFBq7UvHTzgt00B8l8Yu6wez4EZfUa-DU4vT86c-kkFJwm4t3a8lMYi8QUPDCgCSnGZqMSNXUO5VMIYMEspNSmPYdWLpch4ZoRyUzfVScpYzNhz0s5hQEfEllrBzGYJjxPpc5nFTPtoHoIGomA_DCzi7CgdFdvMGVF1fSbA4tgSIULaRDVtLNLH6djjYt7rqgCIGtViFHnKpCbzY8YVWIKSap0yFeiYZSmYZtRY5DVOZrQNIt1Lb9RDs5BJsJ0s8rbCwNwXOTrX_NCbsoyGX2f_gDSdNJDe10jZCjgj0XVAA4wJc2o1MI8bmCDBSfNvCyTGrYGf9UYRlrlMYvpw94Za5Ag5c0e6MvIEqMo-NFfw-R23_r36zb4a_4xedblZbbY4DJ8AYBYRDS5vdKZZky8XVRZy5cNyLsSLu_v1kjzwMFgEr9_EMWmvrzfmFbmf3KyX5XWHtMRkhnAuKigByhPaIQf903E46VSnI51KwAGe97sAL9xzhCKs4BRgyL9Di3B4EV79AvrsTVo |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGQWIvwLhoGYMFBAIkssVxHMdCCJXL1GqlIFamvhkncdZKKAlNO8Sf4jdyTi5lkRDiZQ-8xkdxbH_-fE58LoQ8CjgT2tfc4RosHT9NqRNJGjm-lwjjS5FSU-WZHYnxOJxO5ccN8rONhUG3ypYTK6JO8hj_kR94AjQDH5Rf-ar45mDVKLxdbUto1LA4Mj--g8lWvhy-hfV97HmH7yZvBk5TVcCJA-4tHS-hkYh9wQMDZ6GUPIxl7EauoTyUwhiwzCg1CY9g40ehSHlqhHQTN9FxwliEP0CB8i8Djwt0IRPTtYEH3BEETXgeE_SgQcN-kWdmv8ojI_3O8VdVCVifBZdm6IrZK77mZUfd7Tprnjv9Dq__b_N2g1xr9Gy7X2-MLbJhsptkq2Gy0n7apNt-dou8OB6OTobPbZ3ZWErMqa8z7GJeYKi-sUGrtycOXnDYpgD-K4xdVsWDANG3yecLGcQd0stgObeJHWoJyE5jHsWhz8M0YtpH8xg0MAn6QGARp11pVdSZQ1R1fSjA4qonQSEyVIMMi7xGOKxlMe939SBfnKqGRpQnTWJSP2JcgiUcUq0TJgMdsTQB05Qai-whmFQdRLtmL9VHs5iFAAOLPKwkMPdHhs5Fp3pVlmr44eQfhI4_dYSeNEJpDsiMdRPQAWPCnGIdyd2OJDBY3O1thpNxbuCD_kjhM5eFmD7dPaMW2cad0U5dqX4DG17fQv_PzQ_WzdgzehVmJl_VMgxLIDCLiM4u63xMtyWbz6os7NKH40yInb93vkeuDibvR2o0HB_dJZseBs_gdaTYJb3lYmXukSvx2XJeLu5XVGKTLxe9B38Bg4ewSA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGQYgXYHxogcECAgESWeM4jmMhhAqjWrWqVGxMEy_GSZy1EkpC0w7xr_HXcZePskgI8bIHXuNT3di_-91d7Lsj5EnAmdC-5g7XEOn4aUqdSNLI8b1EGF-KlJqqzuxYTCbhyYmcbpCfbS4MXqtsObEi6iSP8Rt53xPgGfjg_Mp-2lyLmO4N3xTfHOwghSetbTuNGiIH5sd3CN_K16M92Ounnjd8f_Ru32k6DDhxwL2l4yU0ErEveGDALkrJw1jGbuQaykMpjIEojVKT8AhIIApFylMjpJu4iY4TxiL8GAr0f1lAjImB35R_bq0A8EgQNKl6TNB-g4zdIs_MblVTRvodU1h1DFjbhUszvJbZK77mZcf17V7cPGcJhzf-5zW8Sa43_rc9qBVmk2yY7BbZbBiutJ83Zbhf3CavDkfj49FLW2c2thhz6mMOu5gXmMJvbPD27SMHDz5sUwAvFsYuq6ZCgPQ75NOFvMRd0stga7eIHWoJiE9jHsWhz8M0YtrHsBk8Mwl-QmARp911VdQVRVR1rCggEqsXQSFKVIMSi7xFaKxlsR549SBfnKqGXpQnTWJSP2JcQoQcUq0TJgMdsTSBkJUai-wgsFSdXLtmNTXAcJmFAAmLPK4ksCZIhsg41auyVKMPx_8gdPixI_SsEUpzQGmsm0QPeCesNdaR3O5IArPF3dlmuBjnXnx_MFb4zGUhllV3z6hFtlBL2qUr1W-Qw8-3avDn4UfrYZwZbxtmJl_VMgxbIzCLiI7Gdf5MdySbz6rq7NIHMyfEvb9PvkOuguqp8WhycJ9c8zCnBk8pxTbpLRcr84Bcic-W83LxsGIVm3y5aBX8Baq7uTs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SILVI%2C+an+open-source+pipeline+for+T-cell+epitope+selection&rft.jtitle=PloS+one&rft.au=Pissarra%2C+Joana&rft.au=Dorkeld%2C+Franck&rft.au=Loire%2C+Etienne&rft.au=Bonhomme%2C+Vincent&rft.date=2022-09-07&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=9&rft.spage=e0273494&rft_id=info:doi/10.1371%2Fjournal.pone.0273494&rft.externalDBID=ISR&rft.externalDocID=A716438747 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |